DJ ADC Therapeutics Is Maintained at Overweight by Morgan Stanley
Ratings actions from Benzinga: https://www.benzinga.com/stock/ADCT/ratings
(END) Dow Jones Newswires
March 23, 2021 07:57 ET (11:57 GMT)
DJ ADC Therapeutics Price Target Cut to $55.00/Share From $56.00 by Morgan Stanley
Ratings actions from Benzinga: https://www.benzinga.com/stock/ADCT/ratings
(END) Dow Jones Newswires
March 23, 2021 07:57 ET (11:57 GMT)